New York, May 23, 2018: The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Allergan plc, BASF SE, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd., Lonza Group, Mylan, Inc., Sandoz (Novartis AG), Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and WuXiApptec. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The scope of the report includes a detailed study of global and regional markets on Global Active Pharmaceutical Ingredient (API) Market with the reasons given for variations in the growth of the industry in certain regions.

    The Global Active Pharmaceutical Ingredient (API) Market is expected to exceed more than US$ 219.60 Billion by 2023 at a CAGR of 6.3% in the given forecast period.

    You Can Find Full Report @: https://www.marketresearchengine.com/active-pharmaceutical-ingredient-market

    The Global Active Pharmaceutical Ingredient (API) Market is segmented on the lines of its manufacturing process, API type, therapeutic area, drug type and regional. Based on manufacturing process segmentation it covers captive, contract. Based on API type segmentation it covers synthetic chemical API, biological API. Based on therapeutic area segmentation it covers cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, other therapeutics uses.  Based on drug type segmentation it covers branded prescription drugs, generic prescription drugs, OTC prescription drugs.

    The major driving factors of Global Active Pharmaceutical Ingredient (API) Market are as follows:

    • Growing in healthcare expenditure
    • Advancements in the technology of API manufacturing
    • Rapidly increase  aging  population
    • Increasing Importance of Generics
    • Increase in abbreviated new drug applications (ANDA)
    • Growth in Incidence of Chronic Diseases

    The restraining factors of Global Active Pharmaceutical Ingredient (API) Market are as follows:

    • Drug price control policies across different economies are unfavorable
    • Strict regulatory requirements
    • High production cost

    This report provides:

    1) An overview of the global market for Global Active Pharmaceutical Ingredient (API) Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2023.
    3) Identifications of new market opportunities and targeted promotional plans for Global Active Pharmaceutical Ingredient (API) Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    You Can Buy Full Report @: https://www.marketresearchengine.com/active-pharmaceutical-ingredient-market

     

    Table of Contents

    1 INTRODUCTION

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    6 Active Pharmaceutical Ingredients Market, By Type

    7 Active Pharmaceutical Ingredients Market, By Type of Manufacturer

    7.1 Introduction
    7.2 Captive Manufacturers
    7.3 Merchant API Manufacturers
    7.3.1 Merchant Manufacturers Market, By Type
    7.3.1.1 Innovative Merchant API Manufacturers
    7.3.1.2 Generic Merchant API Manufacturers
    7.3.2 Merchant API Manufacturers Market, By Mode of Synthesis
    7.3.2.1 Synthetic APIs
    7.3.2.2 Biotech APIs

    8 Active Pharmaceutical Ingredients Market, By Type of Synthesis

    9 Active Pharmaceutical Ingredients Market, By Type of Drug

    10 Active Pharmaceutical Ingredients Market, By Therapeutic Application

    11 Active Pharmaceutical Ingredients Market, By Region

    12 Competitive Landscape

    13 Company Profiles

    13.1 Introduction

    13.2 Pfizer, Inc.

    13.3 Novartis International AG

    13.4 Sanofi

    13.5 Boehringer Ingelheim

    13.6 Bristol-Myers Squibb

    13.7 Teva Pharmaceutical Industries Ltd.

    13.8 ELI Lilly and Company

    13.9 Glaxosmithkline PLC

    13.10 Merck & Co., Inc.

    13.11 Abbvie Inc.
    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

     

    Source: http://www.financeswire.com/active-pharmaceutical-ingredient-api-market-is-expected-to-grow-us-219-00-billion-by-2023